O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma

Authors:
  • MDM. Ducreux
    M. Ducreux
  • GAG. Abou-Alfa
    G. Abou-Alfa
  • ZRZ. Ren
    Z. Ren
  • JEJ. Edeline
    J. Edeline
  • ZLZ. Li
    Z. Li
  • EAE. Assenat
    E. Assenat
  • LRL. Rimassa
    L. Rimassa
  • JBJ. Blanc
    J. Blanc
  • PRP. Ross
    P. Ross
  • WFW. Fang
    W. Fang
  • SHS. Hu
    S. Hu
  • TZT. Zhang
    T. Zhang
Publisher website
Google Scholar
Abstract
No abstract available